Article
Androgen receptor plasticity and its implications for prostate cancer therapy.
Cancer treatment reviews - 1 Dec 2019
Snow Oliver, Lallous Nada, Singh Kriti, Lack Nathan, Rennie Paul, Cherkasov Artem
Abstract excerpt
Acquired resistance to a drug treatment is a common problem across many cancers including prostate cancer (PCa) - one of the major factors for male mortality. The androgen receptor (AR) continues to be the main therapeutic PCa target and despite the success of modern targeted therapies such as enzalutamide, resistance to these drugs eventually develops. The AR has found many ways to adapt to treatments including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
